Jest to dawka startowa, subterapeutyczna, stosowana w celu adaptacji organizmu
Key Points: GI symptoms are the most common adverse effects, ranging from expected nausea and vomiting to gastroparesis and, rarely, functional obstruction Delayed gastric emptying has important airway implications and a cautious approach to airway management is warranted Biliary disease is one of the most clinically significant complications, particularly early in treatment and with rapid weight loss Pancreatitis is rare, and current evidence does not support a strong causal relationship EDKA and AKI are uncommon but important to recognize in the right context Conclusions: GLP-1 receptor agonists have transformed the management of diabetes and obesity, with clear benefits in weight loss, glycemic control, and cardiovascular outcomes
A separate trial, SELECT, gave cardiologists a reason to pay attention
10.1016/j.heares.2014.04.007 Hear
Glutamic Acid - 5g One of the standout ingredients in this formula is a substantial 5-gram dose of glutamic acid
Timing: Best taken after meals to avoid mild stomach discomfort